Quantitative Assessment of Preventive Behaviors in France during the Fukushima Nuclear Crisis

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Crépey, Pascal ^a,b   Pivette, Mathilde ^a,c   Bar Hen, Avner ^c  

^a EHESP   (France)

^b Aix Marseille University IRD 190 Inserm 1207   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; CONTROLLED STUDY; DRUG MARKETING; DRUG USE; DRUG UTILIZATION; FRANCE; FUKUSHIMA NUCLEAR ACCIDENT; PHYSICIAN ATTITUDE; PRESCRIPTION; PREVENTIVE MEDICINE; QUANTITATIVE ANALYSIS;

FRANCE; FUKUSHIMA NUCLEAR ACCIDENT; HEALTH BEHAVIOR; HUMANS; PHARMACIES; PRESCRIPTION DRUGS; RADIATION-PROTECTIVE AGENTS; TIME FACTORS;

EID: 84874689524     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058385     Document Type: Article

References (14)

1. Nuclear Emergency Response Headquarters Government of Japan (2011) Report of Japanese Government to the IAEA Ministerial Conference on Nuclear Safety- The Accident at TEPCO's Fukushima Nuclear Power Stations.
2. Nuclear and Industrial Safety Agency (2011) INES (the International Nuclear and Radiological Event Scale) Rating on the Events in Fukushima Dai-ichi Nuclear Power Station by the Tohoku District- off the Pacific Ocean Earthquake.
3. Yablokov AV, Nesterenko VB, (2009) Chapter I. Chernobyl Contamination?: An Overview 1. Chernobyl Contamination through Time and Space. Power 30: 4-30.
4. Carlé B, Charron S, Milochevitch A, Hardeman F, (2004) An inquiry of the opinions of the French and Belgian populations as regards risk. Journal of hazardous materials 111: 21-27.
5. Raude J, Caille-Brillet A-L, Setbon M, (2010) The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why? PLoS currents 2: RRN1188.
6. Setbon M, Le Pape M-C, Létroublon C, Caille-Brillet A-L, Raude J, (2011) The public's preventive strategies in response to the pandemic influenza A/H1N1 in France: Distribution and determinants. Preventive medicine 52: 178-181.
7. Vaux S, Van Cauteren D, Guthmann J-P, Le Strat Y, Vaillant V, et al. (2011) Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC public health 11: 30.
8. Institut de Radioprotection et de Sûreté Nucléaire (n.d.). Available: http://www.irsn.fr/EN/news/Pages/news.aspx. Accessed 3 March 2012.
9. Autorité de Sureté Nucléaire (ASN) (n.d.) La distribution d'iode stable autour des centrales nucléaires françaises. Available: http://www.distribution-iode.com. Accessed 8 January 2013.
10. Celtipharm (n.d.) Panel Xpr-SO (c). Available: http://www.xpr-so.com/pages/Public/Accueil.aspx. Accessed 1 November 2011.
11. Kish JL (1965) Survey Sampling. Wiley & Sons.
12. Watkins RE, Eagleson S, Veenendaal B, Wright G, Plant AJ, (2008) Applying cusum-based methods for the detection of outbreaks of Ross River virus disease in Western Australia. BMC medical informatics and decision making 8: 37.
13. Astagneau P, Ancelle T, editors (2011) Surveillance épidémiologique. Paris: Lavoisier.
14. Spallek L, Krille L, Reiners C, Schneider R, Yamashita S, et al. (2011) Adverse Effects of Iodine Thyroid Blocking: a Systematic Review. Radiation protection dosimetry: 1-11.